Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD
Status:
RECRUITING
Trial end date:
2026-05-08
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-blind, multiple dose levels, parallal group, placebo-controlled study, to evaluate the safety, PK profiles and preliminary efficacy of TTYP01 tablets in adolescents and children with ASD.